Item 2.02 Results of Operations and Financial Condition

On May 12, 2023, Timber Pharmaceuticals, Inc. (the "Company") issued a press release announcing its financial results and other information for the quarter ended March 31, 2023. A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K.

The information in this Item 2.02 and Exhibit 99.1 attached hereto is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act") or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.

Item 9.01. Financial Statements and Exhibits.



(d) Exhibits.

Exhibit No.                                     Exhibit

99.1            Press Release issued by the Company on May 12, 2023

104           Cover Page Interactive Date File (embedded within the Inline XRBL document)

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses